Bladder Cancer - Results from #420

Racial disparities in stage at bladder cancer diagnosis in the US Veterans Affairs healthcare system. April 30, 2024

Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/SUO GUIDELINE (2017; Amended 2020, 2024). April 29, 2024

An exploratory study investigating the impact of the bladder tumor microbiome on Bacillus Calmette Guerin (BCG) response in non-muscle invasive bladder cancer. April 29, 2024

Voided urine cytology is a useful tool predicting non-muscle-invasive bladder cancer risk before surgery. April 29, 2024

Immunotherapy for advanced or metastatic urothelial carcinoma: an abridged Cochrane review. April 26, 2024

PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitors. April 26, 2024

Surveillance of non-muscle-invasive bladder cancer with blue-light cystoscopy: a meta-analysis. April 26, 2024

NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer. April 26, 2024

Robotic-assisted radical cystectomy with cutaneous ureterostomies: a contemporary multicenter analysis. April 25, 2024

Phase 1/2 Randomized Clinical Trial of In-clinic acupuncture Prior to Bacillus Calmette-Guérin in Patients with High-risk Non-muscle-invasive Bladder Cancer. April 25, 2024

A Phase II Trial of Intravesical Gemcitabine and Docetaxel in the Treatment of Bacillus Calmette-Guérin‒Naïve Nonmuscle-Invasive Urothelial Carcinoma of the Bladder. April 25, 2024

HIVEC as an alternative option in non-muscle-invasive bladder cancer: Experiences from a high-volume center. April 25, 2024

Preclinical models for bladder cancer therapy research. April 24, 2024

Treatment patterns and clinical outcomes in metastatic urothelial carcinoma: a German retrospective real-world analysis. April 24, 2024

Prognostic Significance of Immune Cell Infiltration in Muscle-invasive Bladder Cancer Treated with Definitive Chemoradiation: A Secondary Analysis of RTOG 0524 and RTOG 0712. April 23, 2024

Healthcare resource utilization and associated costs in patients with metastatic urothelial carcinoma: a real-world analysis using German claims data. April 23, 2024

Predicting non-muscle invasive bladder cancer outcomes using artificial intelligence: a systematic review using APPRAISE-AI. April 22, 2024

Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study. April 22, 2024

Spatial comparison of molecular features associated with resistance to pembrolizumab in BCG unresponsive bladder cancer. April 19, 2024

Clinical variables associated with major adverse cardiac events following radical cystectomy. April 19, 2024

Page 22 of 518